维普期刊资源整合服务平台（V6.5）

102篇 您的检索式：作者名="Kajinami"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	CYP3Ad genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia显示文摘	KAJINAMI K BROUSSEAU M E ORDOVAS J M	2004	Am Cardiol2004，93，1：	1
2	Thedispersion of Au nanoparticles in SiO2/TiO2layeredfilms by the liquid phase deposition(LPD)method显示文摘	Hnin Y K Mizuhata M Kajinami A	2005	Thin Solid Films2005，491，2：	1
3	Cholesterol absorption inhibitors in de- velopment as potential therapeutics 显示文摘	Kajinami K Takekoshi N	2002	Expert Opin Investig Drugs2002，11，6：	1
4	A promoter poly- morphism in cholesterol 7alpha - hydroxylase interacts with apoli- poprotein E genotype in the LDL - lowering response to atorvastatin 显示文摘	Kajinami K Bmusseau ME Ordovas JM	2005	Atherosclerosis2005，180，：	1
5	NK-104: a novel synthetic HMG-CoA reductase inhibitor显示文摘	Kajinami K Mabuchi H Saito Y	2000	Expert Opin Investig Drugs2000，9，11：	1
6	Interactions be- tween common genetic polymorphisms in ABCGS/G8 and CYP7A1 on LDL cholesterol - lowering response to atorvastatin 显示文摘	Kajinami K Brousseau ME Ordnvas JM	2004	Athero- sclerosis2004，175，：	1
7	Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘	Kajinami K Takekoshi N	2002	Exp ()pin Investig Drugs2002，1，6：	1
8	Effects of serum Bvitamins on elevated plasma homocysteine levels associated with the mutatjion of methylenetetrahydrofolate reductase gene in Japanese 显示文摘	Moriyama Y Okamura T Kajinami K	2002	Atherosclerosis2002，164，：	1
9	G enotype-phenotype Correlation in familial hypercholesterolaemia显示文摘	Kajinami K	1999	Nippon Rinsho1999，57，12：	1
10	Poly- morphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gen- der-specific manner显示文摘	Kajinami K Brousseau ME Ordovas JM	2004	Cardiol2004，93，10：	1
11	Pharmacogenomicsof statin responsiveness显示文摘	Kajinami K Akao H Polisecki E	2005	Am J Cardiol2005，96，9：	1
12	Cholesterol absorption inhibitors in development as potential therapeutics 显示文摘	KAJINAMI K TAKEKOSHI N	2002	Exp Opin Investig Drugs2002，11，6：	1
13	Genotype-phenotype correlations in familial hypercholesterolemia 显示文摘		1999	Nippon Rinsho1999，57，12：	1
14	CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatln in primary hypercholesteroleznia显示文摘	Kajinami K Brousseau ME Ordavas JM	2004	Am J Cardiol2004，93，1：	1
15	NK-104: A novel synthetic HMG-CoA reductase inhibitor 显示文摘	Kajinami K Mabuchi H Saito Y	2000	Expert Opin invest Drugs2000，9，11：	1
16	Cholesterol absorption inhibiltors in development as potential therapeutics显示文摘	Kajinami K Takekoshi N		0，，03：	1
17	Plasma homocysteine level and development of coronary artery disease 显示文摘	Kawashiri M Kajinami K Nohara A	1999	Coron Artery Dis1999，10，7：	1
18	A novel wet process for the preparation of vanadium oxide thin film显示文摘	Aoi Y Kajinami A	1997	J Mater Sci1997，32，：	1
19	NK-104 : A novel synthetic HMG-CoA reductase inhibitor显示文摘	Kajinami K Mabuchi H Saito Y	2000	Expert Opin Invest Drugs2000，9，11：	1
20	Circulating matrix metalloproteinase and their inhibitors in premature coronary atherosclerosis显示文摘	Noji Y Kajinami K Kawashiri M	2001	Clin Chem Lab Med2001，39，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示